Show simple item record

dc.contributor.authorMakoae, L N
dc.contributor.authorPortillo, C J
dc.contributor.authorUys, L R
dc.contributor.authorDlamini, P S
dc.contributor.authorGreeff, M
dc.contributor.authorChirwa, M
dc.contributor.authorKohi, T W
dc.contributor.authorNaidoo, J
dc.contributor.authorMullan, J
dc.contributor.authorWantland, D
dc.contributor.authorDurrheim, K
dc.contributor.authorHolzemer, W L
dc.contributor.authorMakoae, Lucy N.
dc.contributor.authorPortillo, Carmen J.
dc.contributor.authorUys, Leana R.
dc.contributor.authorDlamini, Priscilla S.
dc.contributor.authorGreeff, Minrie
dc.contributor.authorChirwa, Maureen
dc.contributor.authorKohi, Thecla W.
dc.contributor.authorNaidoo, Joanne
dc.contributor.authorMullan, Joseph
dc.contributor.authorWantland, Dean
dc.contributor.authorDurrheim, Kevin
dc.contributor.authorHolzemer, William L.
dc.date.accessioned2010-08-04T15:36:11Z
dc.date.available2010-08-04T15:36:11Z
dc.date.issued2009en_US
dc.identifier.citationMakoae, L.N. et al. 2009. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS care, 21(11):1357-1362, Nov. [http://www.informaworld.com/smpp/1665422813-65939007/home~db=all]en_US
dc.identifier.issn0954-0121
dc.identifier.issn1360-0451 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/3397
dc.description.abstractAIM: This study examined the impact of taking or not taking antiretroviral (ARV) medications on stigma, as reported by people living with HIV infection in five African countries. DESIGN: A two group (taking or not taking ARVs) by three (time) repeated measures analysis of variance examined change in reported stigma in a cohort sample of 1454 persons living with HIV infection in Lesotho, Malawi, South Africa, Swaziland, and Tanzania. Participants self-reported taking ARV medications and completed a standardized stigma scale validated in the African context. Data were collected at three points in time, from January 2006 to March 2007. Participants taking ARV medications self-reported a mean CD4 count of 273 and those not taking ARVs self-reported a mean CD4 count of 418. RESULTS: Both groups reported significant decreases in total HIV stigma over time; however, people taking ARVs reported gnificantly higher stigma at Time 3 compared to those not taking ARVs.
dc.description.urihttp://www.informaworld.com/images/icons/pdf-fulldoc.png
dc.publisherRoutledge
dc.titleThe impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countriesen_US
dc.contributor.researchID10187308 - Greef, Minrie
dc.contributor.researchID12739391 - Uys, Leana


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record